CIMEX
Price
$27.36
Change
+$0.09 (+0.33%)
Updated
Jun 2 closing price
Net Assets
146.54B
RMGSX
Price
$12.73
Change
+$0.01 (+0.08%)
Updated
Jun 2 closing price
Net Assets
610.75M
Interact to see
Advertisement

CIMEX vs RMGSX

Header iconCIMEX vs RMGSX Comparison
Open Charts CIMEX vs RMGSXBanner chart's image
CIMEX vs RMGSX Comparison Chart in %
View a ticker or compare two or three
VS
CIMEX vs. RMGSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and RMGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX has more cash in the bank: 147B vs. RMGSX (611M). CIMEX pays higher dividends than RMGSX: CIMEX (3.23) vs RMGSX (2.49). CIMEX was incepted earlier than RMGSX: CIMEX (24 years) vs RMGSX (9 years). RMGSX (1.08) is less costly to investors than CIMEX (0.83). RMGSX is a more actively managed with annual turnover of: 101.00 vs. CIMEX (65.00). RMGSX has a lower initial minimum investment than CIMEX: RMGSX (0) vs CIMEX (250). RMGSX annual gain was more profitable for investors over the last year : 17.56 vs. CIMEX (8.61). RMGSX return over 5 years is better than : 24.61 vs. CIMEX (23.26).
CIMEXRMGSXCIMEX / RMGSX
Total Expense Ratio0.830.9092%
Annual Report Gross Expense Ratio0.831.0877%
Fund Existence24 years9 years-
Gain YTD5.8517.95674%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B611M24,059%
Annual Yield % from dividends3.232.49130%
Returns for 1 year8.6117.5649%
Returns for 3 years35.1345.5977%
Returns for 5 years23.2624.6195%
Returns for 10 years76.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPCX17.86N/A
N/A
JPMorgan US Large Cap Core Plus C
PICMX40.22N/A
N/A
Virtus KAR Mid-Cap Growth I
OIEJX26.85N/A
N/A
JPMorgan Equity Income R6
MXISX14.85N/A
N/A
Empower S&P SmallCap 600® Index Inv
RYOAX61.16N/A
N/A
Rydex Biotechnology H